The honest answer to whether NAD+ requires a prescription is: it depends entirely on which form you're talking about. NAD+ exists on the market in two very different regulatory categories, one that's sold freely as a supplement and one that legally requires a prescription and medical oversight, and the confusion between the two is one of the most common points of misunderstanding people run into when looking into this compound.
Oral NAD+ Precursors: No Prescription Needed
Oral supplements like nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), and niacin are precursors your body converts into NAD+, and they're classified as dietary supplements under the FDA's DSHEA framework, a classification that's been in place since 1994. Because they fall under this category rather than being regulated as drugs, they don't require a prescription and can be purchased over the counter at retail stores and online without any involvement from a prescriber. This is the pathway most people encounter first, and it's genuinely unrestricted: the FDA has not limited consumer access to these oral precursor products.
Injectable and IV NAD+: Prescription Required
Injectable NAD+, whether given as a subcutaneous injection or through an IV infusion, is an entirely different regulatory situation. This form is a compounded medication, meaning it's prepared by a licensed pharmacy rather than manufactured by a pharmaceutical company under FDA drug approval, and legally obtaining it requires a valid prescription from a licensed medical provider, an MD, DO, nurse practitioner, or physician assistant, operating within their state's scope-of-practice rules. Compounding pharmacies that prepare it operate under Section 503A of the Federal Food, Drug, and Cosmetic Act, which covers traditional compounding pharmacies filling patient-specific prescriptions, or Section 503B, which covers larger-scale outsourcing facilities operating under stricter manufacturing standards. Either way, a prescriber has to be involved before a pharmacy can legally prepare and dispense it.
It's worth being clear about why this distinction exists. NAD+ itself is not FDA-approved as a drug for any specific medical indication, which means the FDA has never evaluated an injectable NAD+ product for safety or effectiveness the way it evaluates approved medications. Instead, NAD+ has remained on the FDA's Category 1 list of substances considered eligible for compounding, reflecting that it has adequate existing safety and usage data to be compounded on a prescription basis, unlike a separate group of peptides the FDA has restricted from compounding entirely over safety concerns. That eligibility, combined with the prescription requirement, is what allows compounding pharmacies to legally prepare and dispense it while it remains formally unapproved as a finished drug product.
How People Actually Access Prescription NAD+
In practice, patients get a prescription for NAD+ therapy in one of two ways: through an in-person visit with an integrative or functional medicine provider, or through a telehealth platform that evaluates the patient and then routes an approved prescription to a compounding pharmacy for fulfillment. State rules on how that evaluation can happen vary meaningfully. Some states allow an entirely asynchronous, telehealth-only evaluation for a patient the provider has already established a relationship with, others require real-time video consultation, and a smaller number require an in-person visit specifically for the first prescription before ongoing care can move to telehealth. Because of that variation, the exact process can look a little different depending on where a patient is located.
What a Prescription Requirement Actually Buys You
The prescription requirement isn't just a bureaucratic hurdle, it's tied to the fact that compounded NAD+ preparations don't go through the FDA safety and quality review that approved drugs do, so the licensed provider and pharmacy are effectively standing in for that missing layer of oversight. A provider evaluation typically includes baseline labs, checking liver and kidney function among other markers, both to establish a safe starting point and to catch anything that should change how the therapy is dosed. Working with a legitimate, accredited compounding pharmacy and a licensed prescriber is also the main safeguard against the quality and purity risks that come with unregulated products.
A Word of Caution About "Research Use Only" NAD+
It's worth flagging a third category that shows up frequently online: NAD+ sold with a "for research use only" label, often at a lower price point than a prescription-based product. These products are legally distinct from both dietary supplements and compounded pharmaceuticals, and they are not authorized for personal or human use under that labeling. There is no legitimate prescription pathway that runs through a research-use-only product, and purchasing one with the intent of using it personally carries real quality, purity, and legal risk, since it hasn't gone through any of the oversight that either the supplement or compounding pathways provide.
The Bottom Line
Whether NAD+ requires a prescription comes down entirely to the form. Oral precursor supplements like NR, NMN, and niacin are legal, unrestricted dietary supplements that anyone can buy without a prescription. Injectable and IV NAD+, by contrast, is a compounded medical product that requires a valid prescription from a licensed provider and must be prepared by an appropriately licensed compounding pharmacy. Products labeled for research use only fall outside both of those legitimate pathways and shouldn't be treated as a shortcut to either one.
If you're considering NAD+ therapy, a licensed provider through IRON Rx can evaluate whether it's appropriate for you and, if so, route a proper prescription to a compounding pharmacy on your behalf.